Media advisory - KLOX Technologies to present its innovative and non-invasive biophotonic technology for acne vulgaris and facial rejuvenation in New York

Dr. Lise Hébert, President and CEO of KLOX Technologies, to present at the Piper Jaffray 25th annual healthcare conference

MONTREAL, Dec. 3, 2013 /CNW Telbec/ - On the heels of reaching an exclusive supply, license and distribution agreement for its acne vulgaris and skin rejuvenation products with Sandoz Canada, KLOX Technologies Inc. ("KLOX") today announced that it will be presenting its strategy and development plans on December 4 at the Piper Jaffray 25th annual healthcare conference, in New York. Dr. Lise Hébert's presentation is entitled "The new generation of effective optical dermatology and tissue repair treatments".

DATEBOOK:

PIPER JAFFRAY 25TH ANNUAL HEALTHCARE CONFERENCE
December 4, 2013, New York

• "The new generation of effective optical dermatology and tissue repair treatments"
  
  Presenter: Dr. Lise Hébert, CEO, KLOX Technologies
  
  Wednesday, December 4, 2:50 to 3:10 p.m. (EST), The New York Palace Hotel, 455 Madison Avenue, New York
  
  KLOX presentation will take place at the Kennedy 1 room.

ON TWITTER
KLOX Technologies corporate account: @KLOXTech

About KLOX Technologies: leveraging light-based biophotonic technologies

http://kloxtechnologies.com/en/investor-relations

KLOX is a privately owned company focused on the development and commercialization of a unique, non-invasive biophotonic technology using a primary device consisting of a multiple LED lighting system that interacts with an oxygen-rich gel containing light-trapping molecules. KLOX's cosmetics and medical devices are destined for the rapidly growing cosmetics, dermatological, tissue repair and dental markets.

SOURCE: KLOX Technologies Inc.

Roch Landriault
NATIONAL Public Relations
1-514-843-2345
[email protected]